Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases.
Huvers
Frank C
FC
Popa
Calin
C
Netea
Mihai G
MG
van den Hoogen
Frank H J
FH
Tack
Cees J
CJ
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D018501:Antirheumatic Agents / Q000494:pharmacology*; D005260:Female; D015309:Glucose Clamp Technique; D006801:Humans; D000069285:Infliximab; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab